Brian Mueller - 02 Dec 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
02 Dec 2022
Net transactions value
-$331,526
Form type
4
Filing time
06 Dec 2022, 20:29:18 UTC
Previous filing
28 Nov 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale $115,054 -1,101 -3.8% $104.50 27,746 02 Dec 2022 Direct F1
transaction BMRN Common Stock Options Exercise $145,046 +2,139 +7.7% $67.81 29,885 02 Dec 2022 Direct F1
transaction BMRN Common Stock Sale $223,526 -2,139 -7.2% $104.50 27,746 02 Dec 2022 Direct F1
transaction BMRN Common Stock Options Exercise $255,033 +3,761 +14% $67.81 31,507 02 Dec 2022 Direct F1
transaction BMRN Common Stock Sale $393,024 -3,761 -12% $104.50 27,746 02 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -2,139 -100% $0.000000* 0 02 Dec 2022 Common Stock 2,139 $67.81 Direct F1, F2
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -3,761 -100% $0.000000* 0 02 Dec 2022 Common Stock 3,761 $67.81 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.